For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent ...

Recently, to my surprise, I came down with bladder cancer. I am a healthy 66-year-old man who is 5 feet, 11 inches tall, 215 ...

As global interest in weight loss remedies grows, the off-label use of diabetes medication Ozempic for shedding pounds in non ...

Don’t be persuaded by the abundance of propaganda you see in ads, newspapers, magazines, TV, and the Internet. There is no ...

Stopping the widespread use of unnecessary, potentially even harmful, cancer screenings can take up to 13 years and ...

WOMEN on fat jabs must take effective contraception, health chiefs have warned for the first time. It comes amid claims of an ...

Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of gastric cancer compared with new users of histamine-2 receptor antagonists (H2RAs). Design Using ...

EVERYONE’S talking about fat jabs – the ‘miracle’ injections trimming inches off waistlines, and helping turn the tide on the ...

E-values were employed to determine the likelihood of unmeasured confounding. • Risk of osteoporosis was lowered by 39% with semaglutide compared to sitagliptin HR: 0.61; 95% CI: 0.38–0.97 • Risk of ...

The Yale University-led research found a "significant association" between exposure to ambient fine particulate matter (PM2.5) air pollution and outdoor artificial light at night and an increased risk ...

HealthDay News — For adults with diabetes and obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for obesity-related cancer compared with dipeptidyl ...